Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05087121
Other study ID # 1684868-2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 16, 2021
Est. completion date July 31, 2022

Study information

Verified date September 2022
Source Pacific University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary aim of this study is to investigate the feasibility, acceptability, and preliminary efficacy of an adapted Cognitive Behavioral Therapy - Insomnia (CBT-I) intervention in improving sleep in a firefighter population.


Description:

After being informed about the study and potential risks, participants will be randomized to the intervention group (group to receive CBT-I) or the no-intervention control group. All participants in the study will complete three assessment visits; one prior to the start of the intervention, one immediately following the 6-week intervention, and one 3-months post-intervention. The intervention group will engage in 6-weeks of CBT-I training aimed at targeting sleep and sleep-related concerns faced as a result of occupational considerations.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date July 31, 2022
Est. primary completion date December 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - English-speaking - full-time professional firefighter - At least 18 years of age - A global Pittsburgh Sleep Quality Index score = 5 (Grandner et al., 2006) - Be willing and able to participate in all study activities including pre-, post-, and 3-month follow up assessments and 6-weeks of the CBT-I intervention - Agree to random assignment to one of two conditions (treatment or control group) - Have access to an email account - Be willing to wear the Fitbit Inspire HR device throughout the duration of the intervention and for two weeks following completion of the 6-week intervention Exclusion Criteria: - Endorsement of prior involvement in formal CBT-I interventions - Unwillingness to give written informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive Behavioral Therapy for Insomnia for Firefighters (CBT-I-F)
The Cognitive Behavioral Therapy for Insomnia for Firefighters (CBT-I-F) 6-week training course has been derived from existing Cognitive Behavioral Therapy for Insomnia (CBT-I) group therapy protocols. Participants in this intervention will receive psychoeducation on sleep and practice skills standard of CBT-I including, stimulus control techniques, sleep restriction, counter-arousal skills, cognitive restructuring, sleep hygiene, goal setting, and relapse prevention skills. Weekly sessions will include discussions regarding difficulties specific to occupational barriers and how to mitigate the impact of occupational requirements on sleep quality.
Device:
Fitbit Inspire HR Wrist Worn Device (NCT04176926)
The Fitbit Inspire HR wrist worn device will be worn by eligible participants throughout the duration of the intervention and for two weeks following completion of the 6-week intervention to collect objective data on enduring sleep changes. This device is an FDA-registered medical device that is not the object of investigation and is being used "on label" only to gather data. 501(K) Number: K200948 Device Name: Fitbit ECG App Regulation Number: 870.2345 Classification Product Code: QDA Clinical Trials: NCT04176926

Locations

Country Name City State
United States Pacific University Forest Grove Oregon

Sponsors (1)

Lead Sponsor Collaborator
Pacific University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Scores on the Pittsburgh Sleep Quality Index (PSQI) The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire designed to assess sleep quality and sleep disfunction throughout the previous month. Global scores range between 0-21 with higher scores indicating greater sleep dysfunction. Baseline (i.e., pre-intervention), 6 weeks (i.e., post-intervention), 18 weeks (i.e., 3-month follow-up)
Primary Total Sleep Time Change as Measured by Actigraphy in the Fitbit Inspire HR Fitbit Inspire HR wrist worn devices will be used to assess mean sleep patterns and sleep-related activity. The Fitbit Inspire HR may be worn consistently for up to 5-days and records wrist movement and heart rate variability to estimate sleep onset, waking, and sleep stages without need for the wearer to actively manipulate the device. Baseline (i.e., pre-intervention), 6 weeks (i.e., post-intervention)
Primary Feasibility as measured by attendance, attrition, and adherence to intervention components. Feasibility will be measured via attendance, attrition rates, and completion of sleep diaries Participant weekly CBT-I attendance will be tracked and analyzed based upon average percentage of total number of sessions attended. Adherence to intervention components will be tracked via compliance with recommendations for the previous week. After each session, sleep diaries for that week will be examined by research assistants and recorded dichotomously as to whether "Yes, the participant was adherent" or "No, the participant was not adherent". An adherence percentage will be calculated. From intervention Week 1 to intervention Week 6
Primary Acceptability as measured by mean acceptability ratings on four Likert-style questions. Acceptability will be assessed using four self-report questions derived from similar studies, and calculated via mean acceptability ratings on a scale of 0-6. These items will include the degree to which the participant liked the program, whether they found the home practice/requirements reasonable, whether they would recommend the program, and whether they would take the program again in the future. Each item is responded to on a 7-point Likert-type scale ranging from 0 to 6, with higher scores indicating greater acceptability. 6 weeks (i.e., post-intervention)
Secondary Depression, Anxiety, and Stress as Measured Through the Depression, Anxiety, and Stress Scales 21 (DASS-21). The Depression, Anxiety, Stress Scales 21-item measure (DASS-21) measures self-report ratings of depression, anxiety, stress symptoms. Items are responded to on a 4-point Likert-type scale ranging from 0 (Did not apply to me at all) and 3 (Applied to me very much or most of the time). Scores range between 0 and 120 for the DASS-21 total score. Higher scores indicate a greater severity of depression, anxiety, and stress. Baseline (i.e., pre-intervention), 6 weeks (i.e., post-intervention), 18 weeks (i.e., 3-month follow-up)
Secondary PTSD as Measured Through the PTSD Checklist for DSM-5 (PCL-5) The PTSD Checklist for DSM-5 (PCL-5) measures self-reported PTSD symptoms. Items are responded to on a 5-point Likert-type scale ranging between 0 (Not at all) to 4 (Extremely) with higher scores indicating greater severity of PTSD symptoms. Items are summed to create a total score ranging between 0-80 and scores greater than 33 indicate probable PTSD. Baseline (i.e., pre-intervention), 6 weeks (i.e., post-intervention), 18 weeks (i.e., 3-month follow-up)
Secondary General Health as Measured Through the Medical Outcomes Study 12-item Short-Form Survey (SF12v2) The Medical Outcomes Study 12-item Short-Form Survey (SF12v2) measures self-reported general health. The SF12v2 is a 12-item self-report that contains eight subscales: physical functioning, role-physical (i.e., role limitations related to physical health), bodily pain, general health, vitality, social functioning, role-emotional (i.e., emotional problems resulting in role limitations), and mental health. Higher scores indicate more favorable states of health. Baseline (i.e., pre-intervention), 6 weeks (i.e., post-intervention), 18 weeks (i.e., 3-month follow-up)
Secondary Family Functioning as Measured Through the McMaster Family Assessment Device - General Functioning Scale (FAD-GFS) The McMaster Family Assessment Device - General Functioning Scale (FAD-GFS) measures self-reported family functioning. The FAD-GFS is a 12-item self-report subscale of the larger 60-item FAD measure, that assesses overall health and pathology of the family. Items on the FAD-GFS are responded to on a 4-point Likert-type scale ranging between 1 (Strongly Agree) and 4 (Strongly Disagree). Higher total scores indicate more problematic family functioning. Baseline (i.e., pre-intervention), 6 weeks (i.e., post-intervention), 18 weeks (i.e., 3-month follow-up)
Secondary Vigilant Attention as Measured Through the Psychomotor Vigilance Task (PVT). The Psychomotor Vigilance Task (PVT) is a continuous performance task commonly used to objectively assess sleep-related cognitive deficits in vigilant attention. The PVT, administered remotely via Inquisit Web software (Millisecond Software LLC, US) will be used in this study. Inter-stimulus intervals are set to vary randomly between 2-10 seconds and subjects are to respond as quickly as possibly by clicking the mouse to stimuli flashed on the screen. Higher scores indicate slower response times and greater number of errors. Baseline (i.e., pre-intervention), 6 weeks (i.e., post-intervention), 18 weeks (i.e., 3-month follow-up)
Secondary Fidelity of Intervention Protocol Across Sessions Fidelity will be assessed to ensure therapist adherence to the intervention protocol in each session. An adherence measure of covered session topics, covered activities, and global instructor skill in presenting material will be used to for each weekly session. Sessions will be audio recorded and two research assistants will independently rate each item regarding covered session topics and covered activities on a 3-point Likert-style scale ranging from 0-2 (0 = not present, 1 = somewhat present, 2 = fully present), and global instructor skill in presenting the material will also be rated on a 3-point Likert-style scale ranging from 0-2 (0 = none, 1 = minimal, 2 = adequate). Higher scores indicate better fidelity. 6 weeks (i.e., post-intervention)
See also
  Status Clinical Trial Phase
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT05963542 - Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia N/A
Completed NCT06339853 - Study of Efficacy of Digital Cognitive Behavioral Therapy With Wearable Device for Insomnia N/A
Recruiting NCT04069247 - Effectiveness of eCBT-I on Improving Mental Health in Chinese Youths With Insomnia N/A
Completed NCT04493593 - Internet-delivered CBT-I (Space for Sleep): Pilot and Feasibility N/A
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Recruiting NCT06278077 - Neurexan - a Clinical Trial in Short-Term Insomnia Patients Phase 2
Completed NCT04661306 - The Better Sleep for Supporters With Insomnia Study N/A
Recruiting NCT06207279 - Preliminary Study on the Development and Reliability and Validity of Attention Rating Scale
Recruiting NCT06006299 - Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC) N/A
Completed NCT03683381 - App-based Intervention for Treating Insomnia Among Patients With Epilepsy N/A
Completed NCT04564807 - Testing an Online Insomnia Intervention N/A
Completed NCT03673397 - The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression N/A
Completed NCT04035200 - Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation Phase 2
Active, not recruiting NCT05027438 - Reducing Use of Sleep Medications Assisted by a Digital Insomnia Intervention N/A
Recruiting NCT06053840 - An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients With Severe Insomnia Phase 4
Not yet recruiting NCT06348082 - Project Women's Insomnia Sleep Health Equity Study (WISHES) N/A
Not yet recruiting NCT06363799 - Osteopathic Protocol for Insomnia in College Students N/A
Not yet recruiting NCT06025968 - Digital Cognitive-behavioral Therapy for Insomnia for Patients With Multiple Sclerosis N/A
Not yet recruiting NCT05991492 - Improving Sleep With a Digital Cognitive Behavioral Therapy for Insomnia Application N/A